Evidence shows that more than 600 essential medicines are at risk, and manufacturing in Europe will ‘grind to a halt’ if wide-ranging chemical ban on Per- and Polyfluoroalkyl Substances (PFAS) substances is implemented.
While we support the need to restrict certain PFAS, we need to find the right approach to ensure the continued manufacturing and availability of medicines in Europe. A total ban would see medicines’ manufacturing in the EU grind to a halt in under three years. It would also jeopardise the production of all pharmaceutical substances in Europe and would be in conflict with the EU’s strategy of reducing Europe's dependency in the event of shortages or pandemics.
Discover more here.
